GleamWall
中文EN

PRVA Privia Health Group, Inc.

Services-Health Services · Nasdaq · SEC CIK 1759655 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY19.2%
TTM net income YoY91.3%
TTM EPS YoY85.7%
Revenue 3-yr CAGR15.5%
Net income 3-yr CAGR-3.0%

Margins

Gross margin—
Operating margin2.1%
Net margin1.4%
FCF margin—
EBITDA margin2.6%

Returns

ROE4.6%
ROA2.4%
ROIC (approx.)10.0%
Asset turnover1.67x

Leverage & solvency

Liabilities / assets44.2%
Debt / equity0.00x
Current ratio1.63x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.11x
Accruals ratio-5.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$656.96M$632.63M$603.85M$541.17M$580.42M$521.15M$480.10M$460.90M
SG&A expense$34.45M$39.66M$41.47M$29.27M$39.64M$37.52M$31.72M$34.42M
Operating income$20.54M$11.77M$7.42M$11.28M$14.40M$3.34M$5.22M$5.25M
Pretax income$22.27M$16.75M$9.31M$13.37M$16.67M$5.74M$8.15M$8.02M
Income tax$7.67M$7.02M$5.60M$2.79M$6.87M$2.46M$2.10M$2.65M
Net income$13.49M$9.05M$3.06M$9.15M$6.86M$2.69M$4.22M$4.40M
EBITDA$24.04M$15.13M$10.70M$13.94M$17.17M$5.92M$7.12M$7.08M
EPS (basic)0.110.070.02—0.060.020.03—
EPS (diluted)0.100.070.02—0.050.020.03—
Weighted avg. shares (diluted)132.71M131.83M130.88M—128.78M128.45M127.75M—
Balance sheet
Cash & equivalents$446.28M$412.20M$419.52M$479.69M$441.35M$390.13M$469.33M$491.15M
Receivables$623.58M$574.16M$513.68M$400.90M$499.04M$443.99M$388.73M$316.18M
Current assets$1.10B$1.03B$966.02M$911.00M$970.93M$882.96M$886.47M$834.82M
PP&E, net$1.02M$272,000$384,000$504,000$662,000$827,000$1.01M$1.24M
Goodwill$215.79M$215.79M$209.84M$209.84M$172.22M$172.22M$141.62M$141.62M
Intangibles$215.29M$218.65M$212.78M$215.92M$167.54M$170.14M$108.13M$109.81M
Total assets$1.56B$1.49B$1.42B$1.37B$1.35B$1.27B$1.18B$1.14B
Current liabilities$674.36M$634.44M$601.30M$568.52M$582.91M$534.85M$470.81M$449.15M
Total liabilities$690.80M$650.51M$611.99M$578.43M$588.23M$539.00M$474.01M$452.34M
Shareholders' equity$815.72M$782.33M$753.06M$737.22M$709.12M$682.86M$659.44M$635.18M
Shares outstanding127.77M126.29M125.69M123.60M122.87M122.67M121.39M120.31M
Cash flow statement
Operating cash flow$28.94M$1.10M-$49.47M$127.50M$51.99M$7.97M-$24.06M$74.80M
Investing cash flow-$1.07M-$11.46M-$26,000-$91.31M-$1.20M-$89.06M$0-$6.26M
Financing cash flow$6.21M$3.04M-$10.67M$2.15M$431,000$1.88M$2.24M$619,000
Depreciation & amortization$3.50M$3.36M$3.28M$2.66M$2.77M$2.58M$1.90M$1.83M
Stock-based compensation$14.03M$19.40M$21.92M$15.45M$18.98M$18.85M$17.79M$15.28M

Free plan shows the latest 8 periods; Pro shows all 27 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.